Gross Margins, Early to Late: What They Do (and Don't) Tell You
a16z
Journal Club: Revisiting Eroom's Law
With @jorgecondebio @vijaypande and @lr_bio
On this special holiday weekend edition of the a16z bio Journal Club we discuss a recent opinion article suggesting the end of Eroom’s Law—the decades long trend in biopharma R&D towards higher and higher costs per new drug—and our take on the big trends in this space.
0:00